Vivanza Biosciences share news, announcements and annual reports
BSE: 530057Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹1.43.
30 Oct: open ₹1.50, high ₹1.60, low ₹1.50
- Next results date: the board meets on 3 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹6.16 Cr4,790th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 13.57
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.41
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 10.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 3.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 2.34
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 24,333
Vivanza Biosciences share news and announcements
594 announcements, routine notices left out, newest first. Page 4 of 12.
Apr 2024
9 Apr · General Corporate Announcement Clarifying To The Mail Received From BSE Pertaining To Unsolicited Messages Being Circulated In The Market.
8 Apr · Disclosure
8 Apr · Regulation 7(3)_Compliance Certificate (RTA & Compliance Officer) For Quarter & Year Ended 31St March, 2024.
Feb 2024
Jan 2024
30 Jan · Board meeting
Meeting on 6 Feb 2024: quarterly results
Dec 2023
Nov 2023
Oct 2023
11 Oct · Board meeting
Meeting on 26 Oct 2023: quarterly results
Sep 2023
1 Sep · Board meeting
Aug 2023
3 Aug · Board meeting
Meeting on 10 Aug 2023: quarterly results
Jul 2023
25 Jul · Meeting
14 Jul · Announcement Under Regulation 30 (LODR)-Non Applicability Of Submission Of Report On Corporate Governance Under Regulation 27 (2)
3 Jul · Compliance-57 (5) : intimation after the end of quarter
1 Jul · Meeting
Jun 2023
26 Jun · Board meeting
Meeting on 30 Jun 2023: annual general meeting
May 2023
Apr 2023
25 Apr · Board meeting